Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates

Loading...
Thumbnail Image

Date

2020

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Abstract

The pharmacokinetics of vancomycin, a drug used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA), varies between paediatric and adult patients. The objective of this study was to assess the pharmacokinetics of vancomycin in preterm neonates and determine the optimum dose regimen.

Description

Keywords

Vancomycin pharmacokinetics, Dose regimen, Preterm Neonates, Adult patients, Paediatric

Citation

9. Mulubwa, M. et al (2020). Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates. Drugs in R and D ,20(2), 105-113